Dermatology Times » Rosacea
247 FOLLOWERS
Dermatology Times is a publication focused on the field of dermatology, founded in 1971. Their content covers a range of topics related to dermatology, including news, research, clinical insights, and industry updates. Get the latest news and trends in dermatologic procedures, therapy, technology, products and drugs at Dermatology Times.
Dermatology Times » Rosacea
7h ago
In case you missed it, this week we had news about the FDA approval of deuruxolitinib for severe alopecia in adults, new nonmelanoma guidelines from the Dermatology Association of Radiation Therapy, Arcutis' submitted sNDA for roflumilast foam for scalp and body psoriasis, and more ..read more
Dermatology Times » Rosacea
8h ago
Investigators looked into pollutant-induced disruption of the skin barrier, increased transepidermal water loss, and heightened inflammatory responses ..read more
Dermatology Times » Rosacea
10h ago
Iltefat Hamzavi, MD, discusses the REGINA 007 phase 2 trial evaluating MK-6194 for the treatment of non-segmental vitiligo ..read more
Dermatology Times » Rosacea
12h ago
A recent study found psoriasis content deemed “unreliable” still obtained 850,000 likes ..read more
Dermatology Times » Rosacea
13h ago
The lotion effectively rebalanced the microbiota, reduced erythema and desquamation, and improved acne severity ..read more
Dermatology Times » Rosacea
16h ago
Along with the approval, Sun Pharma is introducing an access program to assist eligible patients in starting and adhering to the treatment ..read more
Dermatology Times » Rosacea
17h ago
Combining electrocoagulation with pharmacotherapy significantly reduced keloid scar volume by inhibiting collagen deposition, angiogenesis, and cell proliferation ..read more
Dermatology Times » Rosacea
21h ago
In a milestone year for Dermatology Times, our Editorial Advisory Board reflects on how the publication has impacted their practice ..read more
Dermatology Times » Rosacea
21h ago
The study highlights the need for personalized treatments, suggesting that this combination therapy is most beneficial when tailored to individual risk profiles ..read more
Dermatology Times » Rosacea
21h ago
A systematic review of 31 studies found that patients with EBA responded well to rituximab with few adverse effects ..read more